会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
    • 有机化合物的改善或有关
    • WO2009027626A2
    • 2009-03-05
    • PCT/GB2008/002738
    • 2008-08-12
    • SYNGENTA LIMITEDBELL, Gordon, AlastairHARRIS, Clair, LouiseTOVEY, Ian, David
    • BELL, Gordon, AlastairHARRIS, Clair, LouiseTOVEY, Ian, David
    • A01N25/02A01N37/36A01N43/90A01N37/42A01P3/00A01P7/00
    • A01N25/02A01N37/36A01N37/42A01N43/90A01N2300/00
    • A composition comprising a compound of formula I CH 3 CH(OH)CC=O)NR 1 R 2 (I) where R 1 and R 2 are each independently hydrogen; or C 1-6 alkyl, C 2-6 alkenyl or C 3-6 cycloalkyl, each of which is optionally substituted by up to three substituents independently selected from phenyl, hydroxy, C 1-5 alkoxy, morpholinyl and NR 3 R 4 where R 3 and R 4 are each independently C 1-3 alkyl; or phenyl optionally substituted by up to three substituents independently selected from C 1-3 alkyl; or R 1 and R 2 together with the nitrogen atom to which they are attached form a morpholinyl, pyrrolidinyl, piperidinyl or azepanyl ring, each of which is optionally substituted by up to three substituents independently selected from C 1-3 alkyl; and at least one agrochemical selected from the group consisting of Trinexepac ethyl, Mandipropamid, Abamectin and Emamectin, with the proviso that the agrochemical is not abamectin or emamectin when the solvent is N-(B-hydroxyethyl)- lactamide. Such compositions may be, or may be comprised by, emulsion concentrates.
    • 包含式I的化合物CH 3 CH(OH)C C = O)NR 1 R 2(I)的组合物,其中R 1和R 2各自独立地为氢; 或C 1-6烷基,C 2-6烯基或C 3-6环烷基,其各自任选被至多三个独立地选自苯基,羟基,C 1-5烷氧基,吗啉基和NR 3 R 4的取代基取代,其中R 3和R 4各自独立地为C 1 -3烷基; 或任选被至多三个独立地选自C 1-3烷基的取代基取代的苯基; 或R 1和R 2与它们所连接的氮原子一起形成吗啉基,吡咯烷基,哌啶基或氮杂环庚烷环,其各自任选被至多三个独立地选自C 1-3烷基的取代基取代; 和选自Trinexepac乙基,Mandipropamid,阿维菌素和Emamectin的至少一种农药,条件是当溶剂是N-(B-羟乙基) - 乳酰胺时,农药不是阿维菌素或阿维菌素。 这样的组合物可以是或可以由乳液浓缩物组成。